Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The SARS-CoV-2 Nsp3 macrodomain reverses PARP9/DTX3L-dependent ADP-ribosylation induced by interferon signaling
Lilian C. Russo, Rebeka Tomasin, Isaac de Araújo Matos, et al.
Journal of Biological Chemistry (2021) Vol. 297, Iss. 3, pp. 101041-101041
Open Access | Times Cited: 95

Showing 1-25 of 95 citing articles:

Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2
Stefan Gahbauer, G.J. Correy, M. Schuller, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 2
Open Access | Times Cited: 87
Neutralization escape, infectivity, and membrane fusion of JN.1-derived SARS-CoV-2 SLip, FLiRT, and KP.2 variants
Pei Li, Julia N. Faraone, Cheng Chih Hsu, et al.
Cell Reports (2024) Vol. 43, Iss. 8, pp. 114520-114520
Open Access | Times Cited: 27
Characteristics of JN.1-derived SARS-CoV-2 subvariants SLip, FLiRT, and KP.2 in neutralization escape, infectivity and membrane fusion
Pei Li, Julia N. Faraone, Cheng Chih Hsu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 16
PARP14 and PARP9/DTX3L regulate interferon-induced ADP-ribosylation
Pulak Kar, Chatrin Chatrin, N Mimica Dukic, et al.
The EMBO Journal (2024) Vol. 43, Iss. 14, pp. 2929-2953
Open Access | Times Cited: 15
DELTEX E3 ligases ubiquitylate ADP-ribosyl modification on protein substrates
Kang Zhu, Marcin J. Suskiewicz, Andrea Hloušek-Kasun, et al.
Science Advances (2022) Vol. 8, Iss. 40
Open Access | Times Cited: 61
The molecular mechanism of SARS-CoV-2 evading host antiviral innate immunity
Wenjing Gu, Hui Gan, Yu Ma, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 52
NAD+ in COVID-19 and viral infections
Minyan Zheng, Michael Schultz, David Sinclair
Trends in Immunology (2022) Vol. 43, Iss. 4, pp. 283-295
Open Access | Times Cited: 41
Treatment of SARS-CoV-2-induced pneumonia with NAD+ and NMN in two mouse models
Yisheng Jiang, Yong‐Qiang Deng, Huanhuan Pang, et al.
Cell Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 37
SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in cell culture and in mice
Yousef M. Alhammad, Srivatsan Parthasarathy, Roshan Ghimire, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 35
Open Access | Times Cited: 37
Protein post-translational modification in SARS-CoV-2 and host interaction
Nana Cheng, Mingzhu Liu, Wanting Li, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 26
KH-like Domains in PARP9/DTX3L and PARP14 Coordinate Protein–Protein Interactions to Promote Cancer Cell Survival
H. Saleh, Triantafillos Liloglou, Daniel J. Rigden, et al.
Journal of Molecular Biology (2024) Vol. 436, Iss. 4, pp. 168434-168434
Open Access | Times Cited: 10
Discovery of 2-Amide-3-methylester Thiophenes that Target SARS-CoV-2 Mac1 and Repress Coronavirus Replication, Validating Mac1 as an Antiviral Target
Sarah Wazir, Tomi A. O. Parviainen, Jessica J. Pfannenstiel, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6519-6536
Closed Access | Times Cited: 9
PARP14 is regulated by the PARP9/DTX3L complex and promotes interferon γ-induced ADP-ribosylation
Victória Chaves Ribeiro, Lilian C. Russo, Nícolas C. Hoch
The EMBO Journal (2024) Vol. 43, Iss. 14, pp. 2908-2928
Open Access | Times Cited: 8
The mechanisms of catalysis and ligand binding for the SARS-CoV-2 NSP3 macrodomain from neutron and x-ray diffraction at room temperature
G.J. Correy, Daniel W. Kneller, G.N. Phillips, et al.
Science Advances (2022) Vol. 8, Iss. 21
Open Access | Times Cited: 36
SARS-CoV-2 Brain Regional Detection, Histopathology, Gene Expression, and Immunomodulatory Changes in Decedents with COVID-19
Geidy E. Serrano, Jessica E. Walker, Cécilia Tremblay, et al.
Journal of Neuropathology & Experimental Neurology (2022) Vol. 81, Iss. 9, pp. 666-695
Open Access | Times Cited: 34
The Conserved Macrodomain Is a Potential Therapeutic Target for Coronaviruses and Alphaviruses
Anthony K. L. Leung, Diane E. Griffin, Jürgen Bosch, et al.
Pathogens (2022) Vol. 11, Iss. 1, pp. 94-94
Open Access | Times Cited: 31
Protein structure-based in-silico approaches to drug discovery: Guide to COVID-19 therapeutics
Yash Gupta, Oleksandr V. Savytskyi, Matt Coban, et al.
Molecular Aspects of Medicine (2022) Vol. 91, pp. 101151-101151
Open Access | Times Cited: 30
Discovery of compounds that inhibit SARS-CoV-2 Mac1-ADP-ribose binding by high-throughput screening
Anu Roy, Yousef M. Alhammad, Peter R. McDonald, et al.
Antiviral Research (2022) Vol. 203, pp. 105344-105344
Open Access | Times Cited: 29
Mutation of a highly conserved isoleucine residue in loop 2 of several 𝛽-coronavirus macrodomains indicates that enhanced ADP-ribose binding is detrimental to infection
Catherine M. Kerr, Jessica J. Pfannenstiel, Yousef M. Alhammad, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
Exacerbated salmonellosis in poly(ADP-ribose) polymerase 14 deficient mice
Madhukar Vedantham, Lauri Polari, Tiia Rissanen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Zinc-finger PARP proteins ADP-ribosylate alphaviral proteins and are required for interferon-γ–mediated antiviral immunity
Andrew P. Ryan, Sofia E. Delgado-Rodriguez, Matthew D. Daugherty
Science Advances (2025) Vol. 11, Iss. 5
Open Access
Recombinant infectious bronchitis virus containing mutations in non-structural proteins 10, 14, 15, and 16 and within the macrodomain provides complete protection against homologous challenge
Sarah Keep, Katalin Földes, Giulia Dowgier, et al.
Journal of Virology (2025)
Open Access
A molecular toolbox for ADP-ribosyl binding proteins
Sven T. Sowa, Albert Galera‐Prat, Sarah Wazir, et al.
Cell Reports Methods (2021) Vol. 1, Iss. 8, pp. 100121-100121
Open Access | Times Cited: 32
Cytokines and microRNAs in SARS-CoV-2: What do we know?
Fahimeh Zamani Rarani, Bahman Rashidi, Mohammad Hassan Jafari Najaf Abadi, et al.
Molecular Therapy — Nucleic Acids (2022) Vol. 29, pp. 219-242
Open Access | Times Cited: 24
The Activated Macrophage – A Tough Fortress for Virus Invasion: How Viruses Strike Back
Andra Banete, Julia Barilo, Reese Whittaker, et al.
Frontiers in Microbiology (2022) Vol. 12
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top